Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOPT: Risedronate for Bone Loss Prevention in Men with Epilepsy
NCT00869622Phase 4Completed
- Sponsor
- Boston VA Research Institute
- Start
- Jun 2006
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in osteoporosis, sponsored by Boston VA Research Institute. Started Jun 2006; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00869622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869622.